December 2023

Aculife Healthcare Pvt. Ltd Company is a part of Nirma Group & it is one of world's largest Infusion & Injectable Company, having a State-of-the art manufacturing facility spread over 550 acres of land located near Ahmedabad, Gujarat. Aculife healthcare has global operation in more than 100 countries and it has subsidiaries in Brazil, Mexico & Vietnam. The manufacturing facility has 2 plants with FFS technology, 1 Glass injectable plant and a one dedicated R&D center equipped with advance technology and unmatched research team.

WHO has added the R21/Matrix-M malaria vaccine to its list of prequalified vaccines. In October 2023, WHO recommended its use for the prevention of malaria in children following the advice of the WHO Strategic Advisory Group of Experts (SAGE) on Immunization and the Malaria Policy Advisory Group. The prequalification means larger access to vaccines as a key tool to prevent malaria in children with it being a prerequisite for vaccine procurement by UNICEF and funding support for deployment by Gavi, the Vaccine Alliance.

Takeda announced that LIVTENCITY (maribavir) has been approved by the National Medical Products Administration (NMPA) of China for the treatment of adult patients with post-hematopoietic stem cell transplant (HSCT) or solid organ transplant (SOT) cytomegalovirus (CMV) infection/disease that is refractory to treatment (with or without genotypic resistance) with ganciclovir, valganciclovir, cidofovir or foscarnet. LIVTENCITY is the first and only inhibitor of CMV-specific UL97 protein kinase in China for this indication.

Sanofi is discontinuing the global clinical development program of tusamitamab ravtansine. The decision is based on the outcome of a prespecified interim analysis of the Phase 3 CARMEN-LC03 trial evaluating tusamitamab ravtansine as monotherapy compared to docetaxel in previously treated patients with metastatic non-squamous (NSq) non-small cell lung cancer (NSCLC) whose tumors express high levels of carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5).

FOREMOST MEDITECH has received the award for best promising company for healthcare medical devices by Medgate.

The event was honored with the presence of  Cmdr.Surender Singh War Veteran & Leader BJP who was chief guest. Other guests include Rajiv Nath, Forum coordinator AiMED and Dr Girdhar Gyani, Director General AHPI.

NIPER Ahmedabad was initiated with three specializations Biotechnology, Natural Products and Pharmaceutics and over the period of time three more specializations Pharmaceutical Analysis, Medicinal Chemistry and Pharmacology and Toxicology were added in 2010. Subsequently in 2011, to cater the needs of Medical device industry in India, another feather was added to the cap of NIPER Ahmedabad in the form of specialization in Medical Devices.

Post : Research Associate (RA)

The CSIR-Institute of Himalayan Bioresource Technology, Palampur is one of the National Institutes under the Council of Scientific & Industrial Research which is an autonomous body working under the Department of Scientific and Industrial Research, Ministry of Science & Technology, Government of India. It is spread over 226.1 acres of land with the backdrop of snow-covered peaks of Dhauladhar Range in salubrious climate.

District Health & Family Welfare Society, District Panipat invites applications on the prescribed format from the eligible candidate for filling up of the following vacant posts through prescribed selection criteria at the Civil Surgeon Office, Panipat, Haryana under National Health Mission, Haryana purely on contract basis initially upto 31.03.2024 with detail as mentioned below. (Candidate must go through the instructions uploaded on National Health Mission, Haryana website i.e. nhmharyana.gov.in before applying).